Fathia Mami-Chouaib

7PUBLICATIONS
46CO-AUTHORS
Molecular targetsTumour immunologyMechanobiologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 04, 2025
Patritumab deruxtecan in HR+HER2- advanced breast cancer: a phase 2 trial.

Barbara Pistilli, Fernanda Mosele, Noemie Corcos

|Oct 07, 2024
Author Correction: Sepsis-trained macrophages promote antitumoral tissue-resident T cells.

Alexis Broquet, Victor Gourain, Thomas Goronflot

|Apr 29, 2024
Sepsis-trained macrophages promote antitumoral tissue-resident T cells.

Alexis Broquet, Victor Gourain, Thomas Goronflot

|Aug 30, 2023
FOXO1 Inhibition Generates Potent Nonactivated CAR T Cells against Solid Tumors.

Maude Marchais, Luca Simula, Mélanie Phayanouvong

|Jan 19, 2023
Mutant and non-mutant neoantigen-based cancer vaccines: recent advances and future promises.

Mohamad Omar Ashi, Fathia Mami-Chouaib, Stéphanie Corgnac

Pageof 2